6505--Denali Therapeutics, Inc. 12/01/2026 - 11/30/2031

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC FEDERAL SUPPLY SCHEDULE (36F797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

3F79727D0016

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
This award notice pertains to a procurement activity conducted by the Department of Veterans Affairs, specifically through the NAC Federal Supply Schedule (FSS), under the office identifier 36F797. The contract, identified by procurement number 3F79727D0016, is awarded to Denali Therapeutics, Inc. and covers the period from December 1, 2026, through November 30, 2031. The notice remains active as of its posting date, May 11, 2026. The scope of this procurement falls under the North American Industry Classification System (NAICS) code 325412, which is defined as Pharmaceutical Preparation Manufacturing. The associated Product Service Code is 6505, indicating a focus on pharmaceutical products. The primary objective of this contract is to secure pharmaceutical preparations from Denali Therapeutics, Inc., ensuring a reliable supply of these products for the Department of Veterans Affairs over the five-year contract period. The intended outcome is to support the VA’s mission of providing high-quality healthcare and related services to veterans by maintaining access to essential pharmaceutical products. Contractors should note that this procurement is managed through the Federal Supply Schedule, which is designed to streamline acquisition processes and ensure compliance with federal standards. Key requirements and expected deliverables include the consistent manufacturing and supply of pharmaceutical preparations as specified by the VA. While the notice does not detail specific product types or quantities, it is clear that the deliverables must align with the standards and needs of the VA healthcare system. The contracting entity is the NAC Federal Supply Schedule, a federal office within the Department of Veterans Affairs. The primary point of contact for this procurement is the FSS Help Desk, which can be reached via email at [email protected] or by phone at (708) 786-7737. Contractors seeking further information or clarification are encouraged to utilize these contact channels. This procurement is classified as an award notice, indicating that the contract has already been granted and is not open for competition. There is no information provided regarding set-aside requirements or special considerations such as small business preferences or socioeconomic programs. Contractors evaluating this opportunity should recognize that the contract’s core elements—pharmaceutical manufacturing, federal supply schedule management, and VA healthcare support—will remain constant throughout its lifecycle. The notice and additional details can be accessed via the SAM.gov opportunity ID 873df31601484146a90fbb6c4c8d0293. In summary, this award notice represents a long-term commitment by the Department of Veterans Affairs to procure pharmaceutical preparations from Denali Therapeutics, Inc., supporting the ongoing healthcare needs of veterans nationwide.